Trending
- Kenya, Tanzania braces for torrential floods as Cyclone Hidaya approaches
- EAC monetary affairs committee to discuss single currency progress in Juba talks
- Transport and food prices drive down Kenya’s inflation to 5% in April
- Payment for ransomware attacks increase by 500 per cent in one year
- History beckons as push for Kenya’s President Ruto to address US Congress gathers pace
- IMF’s Sub-Saharan Africa economic forecast shows 1.2 percent GDP growth
- The US Congress proposes extending Agoa to 2041, covering all African countries
- Millions at risk of famine as fuel tax row halts UN aid operations in South Sudan
Browsing: Chairman of Marcyrl Pharmaceutical Industries.
- Marcyrl Pharmaceutical get investments from Development Partners International and Amethis meant to promote greater access to critical care medications in Africa.
- Through its global distribution network, Marcyrl’s goal is to increase access to specialised medications in Egypt and throughout Africa
- Africa has a sizable pharmaceutical industry worth US$18 billion annual demand for packaged medicines, Nevertheless, over 60 per cent of goods are still imported.
Leading Egyptian pharmaceutical company, Marcyrl Pharmaceutical Industries, which specialises in specialty generics, on thursday 6 2023, revealed a new investment meant to speed up its goal of promoting greater access to critical care medications throughout Africa.
The infusion of a substantial minority investment from Development Partners International and Amethis will enable the company to strengthen its institutional framework, leverage its prominent market position, and diversify its product portfolio. This strategic move will enhance the company’s growth potential and create opportunities for increased profitability.
Marcyrl, …
